List view / Grid view
22 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
An international study has shown that the drug-molecule ebselen can correct many of the toxic characteristics of a protein that causes some cases of hereditary motor neurone disease...
22 May 2018 | By SCIEX
Several case studies using X500B QTOF System from SCIEX will illustrate the 1st development stages of a new multispecific antibody with the characterisation of unusual modifications (such as sulfation, additional glycosylation) & structural heterogeneity with both traditional methods, as well as native SEC-MS method...
22 May 2018 | By European Pharmaceutical Review
Nanoparticles could offer a new way to help eradicate the disease worldwide...
21 May 2018 | By European Pharmaceutical Review
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
21 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Pregnant mothers may use rheumatoid arthritis drugs without increased health risks to unborn baby...
18 May 2018 | By European Pharmaceutical Review
Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth...
17 May 2018 | By European Pharmaceutical Review
Discovery of a pathway linking Alzheimer's disease and Type 2 diabetes leads to new strategies to preserve brain health...
17 May 2018 | By European Pharmaceutical Review
An international team of scientists have developed a novel tool to accurately predict eye, hair and skin colour from human biological material...
16 May 2018 | By European Pharmaceutical Review
Researchers describe how a new drug is able to reduce the symptoms and activate the dormant neurons characteristic of Rett Syndrome...
16 May 2018 | By European Pharmaceutical Review
New catalyst is specifically tuned to integrate fluorine atoms into a new organic product...
16 May 2018 | By European Pharmaceutical Review
The FDA has approved Gilenya to treat relapsing multiple sclerosis in children and adolescents age 10 years and older...
15 May 2018 | By European Pharmaceutical Review
The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, heart attack and stroke...
15 May 2018 | By European Pharmaceutical Review
By engineering a special molecule to track certain immune cells in the body, scientists have invented a litmus test for the effectiveness of a newly devised cancer therapy...
15 May 2018 | By Thermo Fisher Scientific
This webinar will address some of the challenges faced by regulated and non-regulated labs as they move to cloud technology, the importance of implementing an extensible lab informatics platform solution and how digital technology has the potential to change how science is performed...
15 May 2018 | By European Pharmaceutical Review
The approval provides paediatric epilepsy patients a treatment option which can be initiated at a therapeutic dose from day one...
Send this to a friend
Follow: